Cerebrospinal fluid neopterin and β2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment
- 1 November 1992
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 20 (6) , 313-315
- https://doi.org/10.1007/bf01710672
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complexAIDS, 1992
- Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.BMJ, 1989
- Serum 2-Microglobulin Decreases in Patients with AIDS or ARC Treated with AzidothymidineThe Journal of Infectious Diseases, 1989
- Elevated neopterin and beta2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infectionAIDS, 1989
- Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1AIDS, 1989
- Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohortBMJ, 1988
- The AIDS dementia complex: I. Clinical featuresAnnals of Neurology, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Measurement of beta-2-microglobulin in serum and plasma by an enzyme-linked immunosorbent assay (ELISA)Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Isoelectric Focusing Followed by Silver StainingEuropean Neurology, 1984